| Product Code: ETC5306069 | Publication Date: Nov 2023 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
The pneumonia vaccine import shipments to Fiji in 2024 continued to be dominated by top exporters including New Zealand, USA, Australia, India, and Taiwan, Province of China. Despite a high concentration of market share as indicated by the high Herfindahl-Hirschman Index (HHI), the market experienced a significant decline with a negative Compound Annual Growth Rate (CAGR) of -57.08% from 2020 to 2024. The growth rate further decreased by -57.1% from 2023 to 2024, reflecting a challenging market environment for pneumonia vaccine imports in Fiji.

The pneumonia vaccine market in Fiji plays a crucial role in public health, addressing respiratory infections in vulnerable populations. Government immunization programs and growing awareness of preventive healthcare drive the demand for vaccines.
The increasing prevalence of pneumonia, coupled with government immunization programs, drives the pneumonia vaccine market in Fiji. Efforts to reduce child mortality and improve public health awareness significantly contribute to market growth.
The pneumonia vaccine market faces challenges in terms of affordability and accessibility, particularly in rural areas of Fiji. Distribution logistics for vaccines, as well as public awareness regarding the importance of vaccination, remain key hurdles. Additionally, overcoming vaccine hesitancy and ensuring adequate government support are critical for expanding market penetration.
Healthcare policies prioritize the accessibility of pneumonia vaccines through government-funded immunization programs and partnerships with international organizations to ensure supply.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Fiji Pneumonia Vaccine Market Overview |
3.1 Fiji Country Macro Economic Indicators |
3.2 Fiji Pneumonia Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Fiji Pneumonia Vaccine Market - Industry Life Cycle |
3.4 Fiji Pneumonia Vaccine Market - Porter's Five Forces |
3.5 Fiji Pneumonia Vaccine Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 Fiji Pneumonia Vaccine Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Fiji Pneumonia Vaccine Market Revenues & Volume Share, By Sector, 2021 & 2031F |
3.8 Fiji Pneumonia Vaccine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Fiji Pneumonia Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination in Fiji |
4.2.2 Government initiatives and funding to improve healthcare infrastructure |
4.2.3 Rising incidence of pneumonia cases in Fiji |
4.3 Market Restraints |
4.3.1 High cost associated with pneumonia vaccines |
4.3.2 Limited access to healthcare services in remote areas of Fiji |
4.3.3 Vaccine hesitancy among certain segments of the population |
5 Fiji Pneumonia Vaccine Market Trends |
6 Fiji Pneumonia Vaccine Market Segmentations |
6.1 Fiji Pneumonia Vaccine Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 Fiji Pneumonia Vaccine Market Revenues & Volume, By Pneumococcal Conjugate Vaccine, 2021-2031F |
6.1.3 Fiji Pneumonia Vaccine Market Revenues & Volume, By Pneumococcal Polysaccharide Vaccine, 2021-2031F |
6.2 Fiji Pneumonia Vaccine Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Fiji Pneumonia Vaccine Market Revenues & Volume, By Prevnar 13, 2021-2031F |
6.2.3 Fiji Pneumonia Vaccine Market Revenues & Volume, By Synflorix, 2021-2031F |
6.2.4 Fiji Pneumonia Vaccine Market Revenues & Volume, By Pneumovax 23, 2021-2031F |
6.3 Fiji Pneumonia Vaccine Market, By Sector |
6.3.1 Overview and Analysis |
6.3.2 Fiji Pneumonia Vaccine Market Revenues & Volume, By Public, 2021-2031F |
6.3.3 Fiji Pneumonia Vaccine Market Revenues & Volume, By Private, 2021-2031F |
6.4 Fiji Pneumonia Vaccine Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Fiji Pneumonia Vaccine Market Revenues & Volume, By Distribution Partner Companies, 2021-2031F |
6.4.3 Fiji Pneumonia Vaccine Market Revenues & Volume, By Non-governmental Organizations (NGO), 2021-2031F |
6.4.4 Fiji Pneumonia Vaccine Market Revenues & Volume, By Government Authorities, 2021-2031F |
7 Fiji Pneumonia Vaccine Market Import-Export Trade Statistics |
7.1 Fiji Pneumonia Vaccine Market Export to Major Countries |
7.2 Fiji Pneumonia Vaccine Market Imports from Major Countries |
8 Fiji Pneumonia Vaccine Market Key Performance Indicators |
8.1 Percentage increase in vaccination coverage rates in Fiji |
8.2 Number of government-funded vaccination programs implemented |
8.3 Reduction in pneumonia-related hospital admissions in Fiji |
8.4 Number of healthcare facilities equipped to administer pneumonia vaccines |
8.5 Increase in public-private partnerships for vaccine distribution and awareness campaigns |
9 Fiji Pneumonia Vaccine Market - Opportunity Assessment |
9.1 Fiji Pneumonia Vaccine Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 Fiji Pneumonia Vaccine Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 Fiji Pneumonia Vaccine Market Opportunity Assessment, By Sector, 2021 & 2031F |
9.4 Fiji Pneumonia Vaccine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Fiji Pneumonia Vaccine Market - Competitive Landscape |
10.1 Fiji Pneumonia Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Fiji Pneumonia Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here